all about "Rezalyute»
of the drug includes active substance - lipoid PPL 600, supplemented with polyunsaturated phospholipid made from soy lecithin, mono-dialkonatom sodium, refined soybean oil, triglycerides medium-chain and a-tocopherol.These components effectively protect a weakened liver, accelerates regeneration processes in its cells, inhibit the synthesis of collagenous tissue and reduce cholesterol.
main form of release of the drug "Rezalyut" are capsules for oral administration.
the treatment "Rezalyutom" should pay attention to its contraindications.So, it should not be taken if the patient has increased sensitivity to phospholipids, soy, peanuts or other components of the drug, but also has anti-phospholipid syndrome.Cauti
Admission Rules "Rezalyuta»
If the doctor did not give individual guidance hepatoprotector "Rezalyut" take two capsules three times a day.Drink the medicine you need before a meal, at the same time it can not chew, and you need to drink enough water.Duration of treatment "Rezalyutom" is directly related to the disease and its efficacy in the patient.
To date, cases involving incompatibility, intoxication or overdose with this drug are not known.
theory "Rezalyut" can interact with anticoagulants such as warfarin or phenprocoumon, so if hepatoprotective therapy should be combined with these drugs, your doctor may adjust the dose, "Rezalyuta."Clinical Research about hepatoprotector penetration into breast milk has not been so for a period of lactation receiving "Rezalyuta" it is desirable to stop so as not to expose a newborn baby to unnecessary risk and to make breastfeeding as healthy as possible.